When in Rome

The 6th IAS Pathogenesis Conference doesn't really end after the closing session by David Miller In 1987 I attended my first AIDS conference, beginning twenty-four years...

Screen Time

A new study indicates age-based screening can lower hepatitis c mortality by Larry Buhl LifeGuide It is well understood that early detection can prevent serious complications...

Sweet Heart

A statin challenges the drug interaction status quo by Chael Needle LifeGuide Maintaining appropriate levels of lipids (fats or fat-like substances in the blood)—“good” cholesterol (HDL-C),...

Coffee, Pot

Can Caffeine and Cannabis Be Helpful for HCV and HIV? by Larry Buhl Doctors agree that lifestyle choices, such as food and substance intake, play a...

Speed Test

An antigen and antibody combo assay zeroes in on acute infection Treatment Horizons by Chael Needle The diagnosis of acute HIV infection, when the virus is...

Early Bird

Study results show immediate treatment holds promise as a prevention tool by Chael Needle Treatment and prevention make good bedfellows. That’s the idea underscoring the results...

Hurdles Cleared

Approved by the fda, telaprevir and boceprevir usher in a new era of treatment by Larry Buhl The first breakthrough treatments for liver disease to...

Verve for VERxVE

An extended release formulation breaks through by Chael Needle Based on results from the VERxVE study, the FDA recently approved Viramune XR for use in antiretroviral...

B Alert

Researchers explore the dangers of hepatitis B and HIV coinfection by Larry Buhl New research suggests people with chronic hepatitis B virus (HBV) infection have twice...

Care Costs

LifeGuide New HCV Meds Are on the Horizon, but Affordability May Still Remain a Challenge by Larry Buhl This column has covered several antiviral meds in...

LATEST POSTS

Eric Rhein Celebrates Stonewall with Two Kentucky Exhibitions

From June 19 through July 27, Institute 193 in Lexington will present “Lifelines,” an exhibition of Eric Rhein’s photography and related work. Although Rhein’s...

Joe Ede: Advocate